These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34815547)

  • 21. Infliximab for ulcerative colitis.
    Simmons J; Jewell DP
    Dig Liver Dis; 2002 Sep; 34(9):616-8. PubMed ID: 12405245
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful Vedolizumab Therapy in a Sixteen-Year-Old Boy with Refractory Ulcerative Colitis.
    Zoet ID; de Boer NK; de Meij TG
    J Crohns Colitis; 2016 Mar; 10(3):373-4. PubMed ID: 26574489
    [No Abstract]   [Full Text] [Related]  

  • 23. Infliximab rescue therapy in steroid-refractory ulcerative colitis: is more really more?
    Molnár T; Farkas K; Szepes Z; Nagy F; Wittmann T
    Aliment Pharmacol Ther; 2011 Feb; 33(3):412-3. PubMed ID: 21198699
    [No Abstract]   [Full Text] [Related]  

  • 24. In search of a better treatment for ulcerative colitis.
    Sharma MP; Makharia G
    Indian J Gastroenterol; 2003; 22(3):77-8. PubMed ID: 12839375
    [No Abstract]   [Full Text] [Related]  

  • 25. Biosimilar CT-P13 in treating ulcerative colitis in the real world.
    Ribaldone DG; Astegiano M
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):305-306. PubMed ID: 28927246
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifaximin for active ulcerative colitis.
    Guslandi M; Petrone MC; Testoni PA
    Inflamm Bowel Dis; 2006 Apr; 12(4):335. PubMed ID: 16633057
    [No Abstract]   [Full Text] [Related]  

  • 27. Fecal calprotectin evaluation in patients with ulcerative colitis.
    Dogan T; Agilli M
    Dig Dis Sci; 2015 Apr; 60(4):1109-10. PubMed ID: 25586087
    [No Abstract]   [Full Text] [Related]  

  • 28. Infliximab Efficacy and Safety in an Ulcerative Colitis Patient with Systemic Lupus Erythematosus.
    Ben-Horin S; Ungar B; Eliakim R; Langevitz P
    J Crohns Colitis; 2016 Jun; 10(6):752-3. PubMed ID: 26826571
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ulcerative colitis and anti-TNFalpha].
    Nancey S; Moussata D; Flourié B
    Gastroenterol Clin Biol; 2007 Jan; 31(1):84-7. PubMed ID: 17273136
    [No Abstract]   [Full Text] [Related]  

  • 30. Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis?
    Nakase H; Yamamoto S; Matsuura M; Chiba T
    Aliment Pharmacol Ther; 2011 Feb; 33(3):413-4; author reply 414-5. PubMed ID: 21198700
    [No Abstract]   [Full Text] [Related]  

  • 31. The Toronto consensus guidelines for nonhospitalized ulcerative colitis: a welcome update but not the end of the story.
    Ananthakrishnan AN; Kane SV
    Gastroenterology; 2015 May; 148(5):877-80. PubMed ID: 25805424
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab for ulcerative colitis.
    Chey WY; Shah A
    J Clin Gastroenterol; 2005; 39(10):920; author reply 920. PubMed ID: 16208122
    [No Abstract]   [Full Text] [Related]  

  • 33. Infliximab or cyclosporine for severe ulcerative colitis.
    Järnerot G
    Gastroenterology; 2006 Jan; 130(1):286; author reply 287. PubMed ID: 16401502
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ulcerative colitis associated with rectocolitis hemorrhagic: successful treatment with infliximab].
    Godart B; Beau P; Benchellal Z; Bumsel F; Metman E
    Gastroenterol Clin Biol; 2007 Jan; 31(1):88-90. PubMed ID: 17273137
    [No Abstract]   [Full Text] [Related]  

  • 35. Using Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative Colitis.
    Belvis Jiménez M; Maldonado Pérez B; Argüelles-Arias F
    J Crohns Colitis; 2018 Aug; 12(9):1134-1135. PubMed ID: 29788419
    [No Abstract]   [Full Text] [Related]  

  • 36. [Infliximab as treatment for a severe outbreak of ulcerative colitis].
    Ruiz P; San Salvador P; Ortiz de Zárate J; Cabezudo P; Marcé L; Polo F; Blanco S; Orive V
    Gastroenterol Hepatol; 2004; 27(7):430-1. PubMed ID: 15461945
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of a best clinical therapy management on surgery for ulcerative colitis.
    Leal RF; de Lourdes Setsuko Ayrizono M; de Sene Portel Oliveira P; Fagundes JJ; Coy CS
    Tech Coloproctol; 2012 Aug; 16(4):321-2. PubMed ID: 22618210
    [No Abstract]   [Full Text] [Related]  

  • 38. Appendicectomy as a potential therapy for refractory ulcerative proctitis.
    Bageacu S; Coatmeur O; Lemaitre JP; Lointier P; Del Tedesco E; Phelip JM; Roblin X
    Aliment Pharmacol Ther; 2011 Jul; 34(2):257-8. PubMed ID: 21679209
    [No Abstract]   [Full Text] [Related]  

  • 39. Infliximab avoiding colectomy and maintaining remission in pediatric immunosuppressive-naïve ulcerative colitis achieving remarkable mucosal healing.
    Sciaudone G; Pellino G; Guadagni I; Selvaggi F
    Panminerva Med; 2010 Mar; 52(1):91-2. PubMed ID: 20228729
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease?
    Barreiro-de Acosta M; Gisbert JP
    Aliment Pharmacol Ther; 2013 Jul; 38(2):207. PubMed ID: 23772904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.